At the news
? NEUTRALIMPACT 2/10 8-K filed May 29, 2026 at 16:15 ET
AnaptysBio filed an 8-K under Item 7.01 to disclose that it has filed Form 8937 with the IRS regarding the tax treatment of the spin-off of First Tracks Biotherapeutics, Inc. The filing provides stockholders with information on how the dividend is treated for tax purposes and how to adjust their tax basis. This is a routine administrative disclosure with no new financial or operational information.
- AnaptysBio filed Form 8937 with the IRS related to the separation and spin-off of First Tracks Biotherapeutics, Inc.
- The Form 8937 provides guidance on tax treatment of the dividend and change in tax basis for stockholders.
- The information is furnished under Regulation FD and is not deemed filed for Exchange Act purposes.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access